Earning Analysis
Welcome to our in-depth analysis of CytoMed Therapeutics Ltd(GDTC) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of CytoMed Therapeutics Ltd earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency:
Actual
Estimate
Surprise Analysis
No Data
GDTC Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, CytoMed Therapeutics Ltd reported performance for , announced on . The company achieved an EPS of , compared to analyst estimates of by % . Revenue for the quarter reached compared to expectations of by % .
The stock price reacted with a % one-day change and a % five-day change following the earnings release. These movements reflect market reaction in CytoMed Therapeutics Ltd growth trajectory and strategic initiatives.
GDTC Earnings Forecast
Looking ahead, CytoMed Therapeutics Ltd(GDTC) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been No Change by 0%, while EPS estimates have been No Change by 0%. For the upcoming Q3 2025, revenue estimates have been adjusted No Change by 0% . These revisions correlate with a -4.15% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in CytoMed Therapeutics Ltd long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between GDTC's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Revenue Estimates for Q3 2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-4.15%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:520.00K
--
EPS Estimate-Annual FY 2025:-0.17
—
Stock Price1.85
GDTC Revenue and EPS Performance: A Historical Perspective
CytoMed Therapeutics Ltd revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
Earnings Reaction
The chart below shows how GDTC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, GDTC sees a +0.00% change in stock price 10 days leading up to the earnings, and a +0.00% change 10 days following the report. On the earnings day itself, the stock moves by +0.00%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in , the stock changed % on the day following the earnings release and then changed by % over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
No Data
People Also Watch
FAQ
What were the key highlights of GDTC’s latest earnings report for undefined?
How did GDTC’s stock price react after the undefined earnings release?
What are the revenue and EPS estimates for GDTC for undefined?
How does GDTC’s stock price correlate with earnings forecast revisions?
What should investors expect from GDTC’s next earnings report?